These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4729330)

  • 1. Cell-mediated immunity in lung cancer patients: data, problems, and propositions.
    Israel L
    Cancer Chemother Rep 3; 1973 Mar; 4(2):279-81. PubMed ID: 4729330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic value of the tuberculin skin test as a parameter of cellular immunocompetence in cancer patients].
    Sone S; Ogushi F; Tsubura H; Fukuoka M
    Kekkaku; 1983 Oct; 58(10):559-62. PubMed ID: 6319794
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic status in lung cancer].
    Briusov PG; Polovoĭ AM
    Sov Med; 1983; (3):16-9. PubMed ID: 6857368
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of delayed hypersensitivity to tuberculin in 130 cancerous adults. Effects of BCG].
    Israel L; Mawas C; Bouvrain A; Mannoni P; Sors C
    Pathol Biol; 1967; 15(11):597-601. PubMed ID: 4860736
    [No Abstract]   [Full Text] [Related]  

  • 7. [The status of indices of immunity and hemostasis in patients with lung cancer and their changes due to general anesthesia and surgical trauma].
    Zakharov VG; Saltanov AI; Rukhadze GA; Zarkua ZP; Dmitrieva NV
    Anesteziol Reanimatol; 1992; (3):41-4. PubMed ID: 1463234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
    Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
    Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in immunoregulatory cells in lung cancer and smoking.
    Ginns LC; Miller LG; Goldenheim PD; Goldstein G; Bria WF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):90S-94S. PubMed ID: 6982280
    [No Abstract]   [Full Text] [Related]  

  • 10. [The DNCB test in pneumology].
    Polistina D
    Arch Monaldi; 1977; 32(3):15-8. PubMed ID: 616268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parameters of cellular immunity in subjects with bronchial squamous cell tumors].
    Vietti Ramus G; Tartaglino B; Cesano L; Revello F; Barbalonga A
    Minerva Med; 1983 Apr; 74(16):879-87. PubMed ID: 6601781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation.
    Jansen HM; Esselink MT; Orie NG; The TH
    Neth J Med; 1979; 22(1):1-9. PubMed ID: 216940
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: First-time microcinematographic documentation of tumor-specific, cellular immune reactions pulmonary in squamous epithelial carcinoma].
    Micksche M
    MMW Munch Med Wochenschr; 1975 May; 117(22):966-7. PubMed ID: 807823
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cell mediated immunity in lung cancer].
    Szczepaniec M
    Folia Med Cracov; 1979; 21(1):49-72. PubMed ID: 396193
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB; Catalona WJ; Twomey PL; Sample WF
    Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous reactions to tuberculin in cancer patients. Prognostic value].
    Israël L; Mawas C; Bouvrain A; Sors MC
    Bull Mem Soc Med Hop Paris; 1967 Mar; 118(5):469-76. PubMed ID: 6075134
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
    Klein E
    Proc Natl Cancer Conf; 1972; 7():567-78. PubMed ID: 4764924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of clinical significance of tuberculin sensitization in patients with lung cancer].
    Knoring BE; Ariél' BM
    Probl Tuberk; 1996; (2):26-30. PubMed ID: 8657690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of DNCB and tuberculin skin tests in relation to the various histological types of pulmonary cancer].
    Soresi V; Invernizzi G; Schiraldi G; Borghini U; Sacerdoti C; Maruzzi M
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):216-21. PubMed ID: 6275868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.